Growing community of inventors

San Diego, CA, United States of America

Hui-Kang Wang

Average Co-Inventor Count = 4.53

ph-index = 5

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 79

Hui-Kang WangQian Shi (11 patents)Hui-Kang WangKuo-Hsiung Lee (8 patents)Hui-Kang WangChing-Yuan Su (7 patents)Hui-Kang WangCharles C-y Shih (6 patents)Hui-Kang WangChawnshang Chang (4 patents)Hui-Kang WangJunko Ishida (4 patents)Hui-Kang WangHideji Itokawa (4 patents)Hui-Kang WangCharles C Y Shih (4 patents)Hui-Kang WangKenneth F Bastow (3 patents)Hui-Kang WangCharles Shih (3 patents)Hui-Kang WangLi Lin (3 patents)Hui-Kang WangHironori Ohtsu (3 patents)Hui-Kang WangYung-Chi Cheng (2 patents)Hui-Kang WangToshio Kitamura (2 patents)Hui-Kang WangXin Guo (2 patents)Hui-Kang WangToshiyuki Kawashima (2 patents)Hui-Kang WangMing Chen (1 patent)Hui-Kang WangLouis Mark Cosentino (1 patent)Hui-Kang WangHironari Ohtsu (1 patent)Hui-Kang WangJohn Robert Vance (1 patent)Hui-Kang WangI-Chen Sun (1 patent)Hui-Kang WangMasayoshi Oyama (1 patent)Hui-Kang WangCharles C-Y Shih (1 patent)Hui-Kang WangCharles Cy Shih (1 patent)Hui-Kang WangHironari Ohtsu (1 patent)Hui-Kang WangCharles C Shih (1 patent)Hui-Kang WangChing-Yuan Su (1 patent)Hui-Kang WangChing-Yuan Su (0 patent)Hui-Kang WangToshio Kitumura (0 patent)Hui-Kang WangCharles C-Y Shih (0 patent)Hui-Kang WangCharles C-Y Shih (0 patent)Hui-Kang WangChing-Yuan Su (0 patent)Hui-Kang WangCharles CY Shih (0 patent)Hui-Kang WangCharles Cy Shih (0 patent)Hui-Kang WangMing S Chen (0 patent)Hui-Kang WangMasayoshi Oyama (0 patent)Hui-Kang WangCharles C Y Shih (0 patent)Hui-Kang WangHui-Kang Wang (18 patents)Qian ShiQian Shi (13 patents)Kuo-Hsiung LeeKuo-Hsiung Lee (56 patents)Ching-Yuan SuChing-Yuan Su (7 patents)Charles C-y ShihCharles C-y Shih (6 patents)Chawnshang ChangChawnshang Chang (9 patents)Junko IshidaJunko Ishida (4 patents)Hideji ItokawaHideji Itokawa (4 patents)Charles C Y ShihCharles C Y Shih (4 patents)Kenneth F BastowKenneth F Bastow (15 patents)Charles ShihCharles Shih (3 patents)Li LinLi Lin (3 patents)Hironori OhtsuHironori Ohtsu (3 patents)Yung-Chi ChengYung-Chi Cheng (61 patents)Toshio KitamuraToshio Kitamura (10 patents)Xin GuoXin Guo (7 patents)Toshiyuki KawashimaToshiyuki Kawashima (2 patents)Ming ChenMing Chen (21 patents)Louis Mark CosentinoLouis Mark Cosentino (3 patents)Hironari OhtsuHironari Ohtsu (2 patents)John Robert VanceJohn Robert Vance (1 patent)I-Chen SunI-Chen Sun (1 patent)Masayoshi OyamaMasayoshi Oyama (1 patent)Charles C-Y ShihCharles C-Y Shih (1 patent)Charles Cy ShihCharles Cy Shih (1 patent)Hironari OhtsuHironari Ohtsu (1 patent)Charles C ShihCharles C Shih (1 patent)Ching-Yuan SuChing-Yuan Su (1 patent)Ching-Yuan SuChing-Yuan Su (0 patent)Toshio KitumuraToshio Kitumura (0 patent)Charles C-Y ShihCharles C-Y Shih (0 patent)Charles C-Y ShihCharles C-Y Shih (0 patent)Ching-Yuan SuChing-Yuan Su (0 patent)Charles CY ShihCharles CY Shih (0 patent)Charles Cy ShihCharles Cy Shih (0 patent)Ming S ChenMing S Chen (0 patent)Masayoshi OyamaMasayoshi Oyama (0 patent)Charles C Y ShihCharles C Y Shih (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Androscience Corporation (9 from 9 patents)

2. University of North Carolina at Chapel Hill (5 from 1,269 patents)

3. Other (3 from 832,680 patents)

4. University of Rochester (3 from 970 patents)

5. Allianz Pharmascience Ltd. (3 from 3 patents)

6. Plantaceutica, Inc. (1 from 1 patent)

7. The University of Tokyo (1,278 patents)


18 patents:

1. 9562025 - Compounds with (1E, 6E)-1,7-Bis-(3,4-dimethoxyphenyl)-4-4-distributed-hepta-1,6-diene-3,5-dione structural scaffold, their biological activity, and uses thereof

2. 9446127 - Compositions including androgen receptor degradation (ARD) enhancers and methods of prophylactic or therapeutic treatment of skin disorders and hair loss

3. 9359279 - Treatment of cancer, inflammatory disease, and autoimmune disease

4. 9259402 - Compounds with (1 E, 6E)-1,7-bis-(3,4-dimethoxyphenyI)-4,4-disubstituted-hepta-1,6-diene-3,5-dione structural scaffold, their biological activity, and uses thereof

5. 9000222 - Compounds with (1E, 6E)-1,7-bis-(3,4-dimethoxyphenyl)-4,4-disubstituted-hepta-1,6-diene-3,5-dione structural scaffold, their biological activity, and uses thereof

6. 8822732 - 1,5-diphenyl-penta-1,4-dien-3-one compounds

7. 8710272 - Compounds with (1 E, 6E)-1,7-bis-(3,4-dimethoxyphenyl)-4,4-disubstituted-hepta-1,6-diene-3,5-dione structural scaffold, their biological activity, and uses thereof

8. 8236852 - Compounds with (substituted phenyl)-propenal moiety, their derivatives, biological activity, and use thereof

9. 8202905 - Compounds with (substituted phenyl)-propenal moiety, their derivatives, biological activity, and use thereof

10. 8198323 - Curcumin analogues and uses thereof

11. 7709535 - Curcumin analogues and uses thereof

12. 7355081 - Curcumin analogues and uses thereof

13. 6903133 - Anticancer compounds

14. 6790979 - Curcumin analogues and uses thereof

15. 6624317 - Taxoid conjugates as antimitotic and antitumor agents

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/4/2025
Loading…